Francesca Curreli

1.4k total citations
38 papers, 1.2k citations indexed

About

Francesca Curreli is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Francesca Curreli has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 24 papers in Virology and 11 papers in Molecular Biology. Recurrent topics in Francesca Curreli's work include HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (22 papers) and Hepatitis C virus research (7 papers). Francesca Curreli is often cited by papers focused on HIV Research and Treatment (24 papers), HIV/AIDS drug development and treatment (22 papers) and Hepatitis C virus research (7 papers). Francesca Curreli collaborates with scholars based in United States, Russia and Italy. Francesca Curreli's co-authors include Asim K. Debnath, Ornella Flore, Alvin E. Friedman‐Kien, Andrea Altieri, Hongtao Zhang, Alexander V. Kurkin, Dmitry S. Belov, Young Do Kwon, Xin Tong and Peter D. Kwong and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Molecular Biology and Journal of Virology.

In The Last Decade

Francesca Curreli

38 papers receiving 1.2k citations

Peers

Francesca Curreli
Blanda Stammen United Kingdom
Pin‐Fang Lin United States
Mika Okamoto Japan
Marina K. Kukhanova Russia
David J. Clanton United States
Boshi Huang China
Kathy A. Aldern United States
Jinkui Niu United States
Marie‐Line Andréola France
Ronna E. Dornsife United States
Blanda Stammen United Kingdom
Francesca Curreli
Citations per year, relative to Francesca Curreli Francesca Curreli (= 1×) peers Blanda Stammen

Countries citing papers authored by Francesca Curreli

Since Specialization
Citations

This map shows the geographic impact of Francesca Curreli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Curreli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Curreli more than expected).

Fields of papers citing papers by Francesca Curreli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Curreli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Curreli. The network helps show where Francesca Curreli may publish in the future.

Co-authorship network of co-authors of Francesca Curreli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Curreli. A scholar is included among the top collaborators of Francesca Curreli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Curreli. Francesca Curreli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Curreli, Francesca, et al.. (2023). Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors. Viruses. 15(4). 1001–1001. 2 indexed citations
2.
3.
Ruiz, Francesc X., et al.. (2021). HIV-1 gp120 Antagonists Also Inhibit HIV-1 Reverse Transcriptase by Bridging the NNRTI and NRTI Sites. Journal of Medicinal Chemistry. 64(22). 16530–16540. 6 indexed citations
4.
Curreli, Francesca, et al.. (2021). Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements. European Journal of Medicinal Chemistry. 224. 113681–113681. 4 indexed citations
5.
Curreli, Francesca, Aleksandra Drelich, Xin Tong, et al.. (2020). Stapled Peptides Based on Human Angiotensin-Converting Enzyme 2 (ACE2) Potently Inhibit SARS-CoV-2 Infection In Vitro. mBio. 11(6). 66 indexed citations
6.
7.
Curreli, Francesca, Dmitry S. Belov, Young Do Kwon, et al.. (2018). Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120. European Journal of Medicinal Chemistry. 154. 367–391. 39 indexed citations
8.
Wang, Yan, Francesca Curreli, Wei Xu, et al.. (2017). Antiviral Activity of Dual-acting Hydrocarbon-stapled Peptides against HIV-1 Predominantly Circulating in China.. PubMed. 30(6). 398–406. 2 indexed citations
9.
Curreli, Francesca, Young Do Kwon, Dmitry S. Belov, et al.. (2017). Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120. Journal of Medicinal Chemistry. 60(7). 3124–3153. 53 indexed citations
10.
Curreli, Francesca, et al.. (2016). Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity. Bioorganic & Medicinal Chemistry. 24(22). 5988–6003. 25 indexed citations
11.
Curreli, Francesca, et al.. (2015). Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor. Bioorganic & Medicinal Chemistry. 23(24). 7618–7628. 10 indexed citations
12.
Muppidi, Avinash, Hongtao Zhang, Francesca Curreli, et al.. (2014). Design of antiviral stapled peptides containing a biphenyl cross-linker. Bioorganic & Medicinal Chemistry Letters. 24(7). 1748–1751. 21 indexed citations
13.
Zhang, Hongtao, Francesca Curreli, Abdül Waheed, et al.. (2013). Dual-acting stapled peptides target both HIV-1 entry and assembly. Retrovirology. 10(1). 136–136. 40 indexed citations
14.
Zhang, Hongtao, Francesca Curreli, Xihui Zhang, et al.. (2011). Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain. Retrovirology. 8(1). 28–28. 55 indexed citations
15.
Curreli, Francesca, et al.. (2010). Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Bioorganic & Medicinal Chemistry. 19(1). 77–90. 53 indexed citations
16.
Zhang, Hongtao, Qian Zhao, Shibani Bhattacharya, et al.. (2008). A Cell-penetrating Helical Peptide as a Potential HIV-1 Inhibitor. Journal of Molecular Biology. 378(3). 565–580. 183 indexed citations
17.
Curreli, Francesca, Alvin E. Friedman‐Kien, & Ornella Flore. (2005). Glycyrrhizic acid alters Kaposi sarcoma–associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. Journal of Clinical Investigation. 115(3). 642–652. 86 indexed citations
18.
Curreli, Francesca, Alvin E. Friedman‐Kien, & Ornella Flore. (2005). Glycyrrhizic acid alters Kaposi sarcoma–associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. Journal of Clinical Investigation. 115(3). 642–652. 85 indexed citations
19.
Curreli, Francesca, et al.. (2002). Detection and quantitation of Kaposi's sarcoma-associated herpesvirus (KSHV) by a single competitive-quantitative polymerase chain reaction. Journal of Virological Methods. 107(2). 261–267. 6 indexed citations
20.
Pani, P., Sergio Laconi, Franca Scintu, et al.. (1999). Direct hyperplasia does not enhance the kinetics of liver repopulation in a new model of hepatocyte transplantation in the rat. Journal of Hepatology. 31(2). 354–359. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Blanda Stammen Breakdown of academic impact, for papers by Pin‐Fang Lin Breakdown of academic impact, for papers by Mika Okamoto Breakdown of academic impact, for papers by Marina K. Kukhanova Breakdown of academic impact, for papers by David J. Clanton Breakdown of academic impact, for papers by Boshi Huang Breakdown of academic impact, for papers by Kathy A. Aldern Breakdown of academic impact, for papers by Jinkui Niu Breakdown of academic impact, for papers by Marie‐Line Andréola Breakdown of academic impact, for papers by Ronna E. Dornsife
Rankless by CCL
2026